Our aim in this study is to evaluate the effects of lymphedema on exercise capacity, body composition, functional level and quality of life in lymphedema patients with primary lower extremity involvement.
Who can participate
Age range18 Years – 65 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients who have completed complete decongestive therapy (CBT) Phase 1 treatment within the last 1 month, use Class 3 compression garments, and are scheduled for CBT Phase 2 treatment.
* Patients with stage 2-3 unilateral or bilateral primary lymphedema with lower extremity involvement
* Women and men aged 18-65
* Patients who agreed to participate in the study and received written voluntary consent form.
Exclusion Criteria:
* Patients who do not agree to participate in the study
* Patients without cooperation and compliance
* Presence of phlebo edema, lipedema, cellulitis, lymphocele
* History of lower extremity venous system disease
* Presence of acute infection
* History of malignancy
* Presence of acute/chronic lung disease (history of acute pulmonary embolism, acute bronchial asthma attack, chronic interstitial lung disease)
* Chronic liver failure
* Renal dysfunction
* Uncontrolled hypertension and diabetes mellitus
* Presence of orthopedic disease that may prevent walking (joint limitation, ankylosis, amputation)
* Use of medications known to affect physical performance, heart rate or metabolism (including Beta blockers)
* Patients who have been included in the CPR (Cardiopulmonary resuscitation) program in the last year
What they're measuring
1
30-second sit-stand test (30-s chair-stand test, 30s-CST)